HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADENOSCAN safely and effectively. See full prescribing information for ADENOSCAN. ADENOSCAN® (adenosine) injection,

First Page		Document Content
Date: 2014-08-27 09:57:02 Aging-associated diseases Antiarrhythmic agents Adenosine Nucleosides Purines Vasodilators Cardiac stress test Third-degree atrioventricular block Dipyridamole Medicine Chemistry Cardiology		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ADENOSCAN safely and effectively. See full prescribing information for ADENOSCAN. ADENOSCAN® (adenosine) injection, Add to Reading List Source URL: www.us.astellas.com Download Document from Source Website File Size: 147,42 KB Share Document on Facebook

	NOTICE: INFORMATION DE L’UTILISATEUR Persantine retard 200 mg gélules à libération modifiée dipyridamole Veuillez lire attentivement cette notice avant de prendre ce médicament car elle contient des informations i DocID: 1lxFu - View Document
	NOTICE: INFORMATION DE L’UTILISATEUR Persantine retard GE 150 mg gélules à libération modifiée dipyridamole Veuillez lire attentivement cette notice avant de prendre ce médicament car elle contient des information DocID: 1kR6x - View Document
	NOTICE: INFORMATION DE L’UTILISATEUR Persantine 50 mg/10 ml solution à diluer pour perfusion dipyridamole Veuillez lire attentivement cette notice avant d’utiliser ce médicament car elle contient des informations i DocID: 1kzwn - View Document
	New Zealand Consumer Medicine Information PERSANTIN® 25 mg tablets Dipyridamole tablets This leaflet answers some common questions about PERSANTIN 25 mg tablets. It does not contain all available information. It does n DocID: 1gmoW - View Document
	® Persantin SR 200 mg capsules Dipyridamole Consumer Medicine Information DocID: 1g0Aq - View Document